What is SpyGlass Pharma, Inc. Common Stock's Market Cap?

SpyGlass Pharma, Inc. Common Stock's Market Cap is $952.6M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Enterprise Value?

SpyGlass Pharma, Inc. Common Stock's Enterprise Value is $729.5M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's EV / EBITDA?

SpyGlass Pharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Net Income (TTM)?

SpyGlass Pharma, Inc. Common Stock's Net Income (TTM) is -$56.1M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's EBITDA?

SpyGlass Pharma, Inc. Common Stock's EBITDA is -$61.1M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM)?

SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM) is -1.68, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Net Debt?

SpyGlass Pharma, Inc. Common Stock's Net Debt is -$223.1M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

SpyGlass Pharma, Inc. Common Stock

XNAS · usd

SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

FIGI BBG01HDDMDT4

28.48▲ 0.26 (0.92%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 28.22
Day's Range: 26.68 – 28.70
52-Week Range: 17.06 – 32.88
Volume: 70.6K
Avg Volume: 117.4K

Share Statistics

Shares Outstanding
Employees: 65
Exchange: XNAS
Listed: 2026-02-06

Share count as of July 29, 2026

SpyGlass Pharma, Inc. Common Stock (SGP) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about SpyGlass Pharma, Inc. Common Stock (SGP)

What is SpyGlass Pharma, Inc. Common Stock's Market Cap?: SpyGlass Pharma, Inc. Common Stock's Market Cap is $952.6M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Enterprise Value?: SpyGlass Pharma, Inc. Common Stock's Enterprise Value is $729.5M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's EV / EBITDA?: SpyGlass Pharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Net Income (TTM)?: SpyGlass Pharma, Inc. Common Stock's Net Income (TTM) is -$56.1M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's EBITDA?: SpyGlass Pharma, Inc. Common Stock's EBITDA is -$61.1M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM)?: SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM) is -1.68, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Net Debt?: SpyGlass Pharma, Inc. Common Stock's Net Debt is -$223.1M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · SGPAs-filed SEC (XBRL) data